Press "Enter" to skip to content

“The President is nervous because the study papers do not arrive” for people over 60 years old

At the beginning of the application of the Sputnik V vaccine against the coronavirus in the country and in the midst of the controversy over its efficacy, the Minister of Health, Ginés González García, admitted to a group of doctors that the President “is nervous” about the lack of papers regarding the studies of the vaccine for those over 60 years of age.

The cameras of the official broadcast captured the moment when a distended Ginés, wearing a mask and sitting with a group of nurses and doctors, confessed the feelings of Alberto Fernández.

The President is nervous because the papers of the study do not arrive, which is the same, but the number of cases of more than 60 years is a thousand something and they want to expand it a little more. But it came out just as effectively, with the same amount of antibodies. I estimate that it is a matter of days, “he said.

In that same talk in the corridors of the Posadas Hospital, the minister also revealed that Fernández intended to be vaccinated: “The President wanted to come here to get vaccinated, but he did get vaccinated. And then he decided that until he can get vaccinated he didn’t want to make any image with this.

Francisco Traverso, UTI doctor, and Flavia Loiacono, medical therapist, the first doctors to receive the Sputnik V vaccine.

Francisco Traverso, UTI doctor, and Flavia Loiacono, medical therapist, the first doctors to receive the Sputnik V vaccine.

“Me too, I’m going to get vaccinated when it’s my turn,” continued the minister, who was accompanied by the Secretary for Access to Health, Carla Vizzotti, among other officials.

Ginés was active at the beginning of the vaccination and witnessed the procedure in one of the hospital rooms. Then he spoke in a relaxed way with Francisco Traverso, an intensive care doctor, and Flavia Loiacono, a medical therapist, who were the first to receive the Sputnik V vaccine. “Che, anyone who faints, you know. If you need a doctor, don’t count on me.”Ginés joked.

But his statement about the President’s “nervousness” did not go unnoticed, after the controversy generated around the efficacy of the vaccine for people over 60, the group most vulnerable to Covid-19.

The debate was generated two weeks ago, when the president of Russia himself, Vladimir Putin, confessed at a conference that the vaccine in his country was not going to be applied yet because “it was not recommended for people over 60 years old.”

Ginés González García, at the Posadas hospital vaccination center.  Photo Guillermo Rodríguez Adami

Ginés González García, at the Posadas hospital vaccination center. Photo Guillermo Rodríguez Adami

“The vaccine has not yet reached people like me,” said Putin, who turned 68 on October 7, which generated doubts and suspicions of all kinds in these pampas. Not only specialists clamored for scientific publications, but also the Buenos Aires Minister of Health, Fernán Quirós, who this Tuesday asked again for the immunization reports.

Just last Saturday the Russian Government authorized Sputnik V vaccination of people over 60 years of age. “The Ministry of Health approved changes to the instructions for use of the drug. Thus, citizens over 60 years of age will also be able to be vaccinated against the coronavirus,” Mikhail Murashko, Minister of Health, told Russian public television.

However, the technical “papers” that Ginés spoke about to begin vaccination in that age group still remain.

Meanwhile, the first 300 thousand doses that arrived in Argentina They began to be applied this Tuesday – as stipulated – in health personnel throughout the country.

The vaccination scheme began at 9 in all the provinces, which in the last hours received the doses in the framework of an operation that included hundreds of preservatives, tons of dry ice and a large number of trucks for its logistics.

The Buenos Aires Governor, Axel Kicillof, the Buenos Aires Vice Minister of Health, Nicolás Kreplak, and a nurse, were the first to receive the dose of the immunization developed by the Gamaleya center.

Sputnik V showed an efficacy of 91.4% in the last control carried out in the third phase of clinical trials, data that, according to the Gamaleya Center, “allow us to affirm with certainty that (Sputnik V) is highly effective and totally safe for health”.

JPE​

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *